The Future of Health Data
Conference

Panel
Mental Health Tech Has Scaled. Has Healing?

Direct-to-consumer mental health platforms have transformed access and engagement across behavioral health, but as adoption grows, a critical question remains: are outcomes actually improving? This conversation brings together leaders across digital health, providers, employers, and policy to examine the evidence behind the mental health tech boom. 

Moderator: Claire Manneh, MPH, Principal, Provider and Research Institutions - Datavant

Speakers:
• Joe Holtschlag, Chief Executive Officer - Ascellus Behavioral Health
• Todd Haedrich, Chief Executive Officer - LIO
• Glen Coppersmith, PhD, Director, Proactive Health Office - ARPA-H
• Kostadin Kushlev, PhD, Associate Professor, Department of Psychology - Georgetown University

Panel
Beyond Weight Loss: The Future Economics of GLP-1s

GLP-1 therapies are rapidly evolving from breakthrough weight loss drugs into a broader healthcare and economic phenomenon. This conversation examines their expanding impact through the lens of long-term economics, reimbursement and payer dynamics, clinical outcomes, employer strategy, and the future of chronic disease management.

Moderator: Sachin Patel, President and GM, Payer - Datavant

Speakers:
• Lotte Bjerre Knudsen, DMSc, Professor, Former Chief Scientific Advisor – Novo Nordisk; Lasker Award and Breakthrough Prizes winner
• Brooke Boyarsky Pratt, Chief Executive Officer - knownwell
• Lauren Esterly, VP Pharmacy Clinical Strategy and Operations - Humana

Panel
The New Provider Playbook: Surviving Margin Pressure, AI, and Consumerization

Health systems are navigating one of the most disruptive periods in modern healthcare: sustained margin pressure, workforce challenges, rising consumer expectations, rapid AI adoption, and increasing competition from nontraditional entrants. This panel brings together leading provider CEOs to discuss how they are redefining strategy, operations, and care delivery for the next era of healthcare.

Moderator: Kristina Bourke, President and GM, Provider - Datavant

Speakers:
• Sanjay Doddamani, MD, MBA, Chief Executive Officer - Guidehealth
• Creagh Milford, DO, MPH, President - Oak Street Health
• Abhi Singh, MD, SVP, Enterprise AI & integration - Jefferson

Closing Fireside
A Conversation with Thomas Keane, National Coordinator for Health Information Technology, and Alya Sulaiman: Building the Infrastructure for Interoperable, AI-Ready Healthcare

Dr. Thomas Keane, Assistant Secretary for Technology Policy and National Coordinator for Health Information Technology (ASTP/ONC) at HHS, joins Alya Sulaiman, Datavant's Chief Privacy Officer & Deputy General Counsel, for a closing conversation on the policy decisions shaping how health data moves, how AI gets built responsibly on top of it, and what's next for interoperability at the federal level.

Fireside Chat
What Does Trusted AI Mean in BioPharma and How Do We Get There?

A fireside conversation with Isaac Kohane, MD PhD on generative AI's impact on healthcare. Moderated by Arnaub Chatterjee, President and GM, Life Sciences at Datavant.

Moderator: Arnaub Chatterjee, President and GM, Life Sciences - Datavant

Speaker:
• Isaac Kohane, MD PhD, Chair of the Department of Biomedical Informatics, Harvard Medical School; Marion V. Nelson Professor of Biomedical Informatics, Harvard Medical School; Professor of Pediatrics, Boston Children's Hospital - Harvard Medical School & NEJM AI

Customer Presentation
Building an AI-enabled Organization, Practical Lessons from an Enterprise Effort

What does it take to build an AI-enabled organization at enterprise scale? In this candid customer presentation, Lana Denysyk shares lessons from Bristol Myers Squibb’s ongoing effort to turn the promise of AI into practical, sustainable capabilities.

Speaker:
• Lana Denysyk, Director of Real-World Data Strategy Enablement - BMS

Panel
Building a Commercial Organization That Wins in the AI Era

AI has real potential to transform commercial execution, but realizing that potential depends on having the right data foundation, governance, and operating model in place across the enterprise. This panel explores what it takes to build the enterprise capabilities and data infrastructure pharma commercial organizations need to compete and win in the AI era.

Moderator: Rachael Scott, Managing Partner, Life Sciences - Datavant

Speakers:
• Daniel C. Lane, PharmD, PhD, MBA, ED & Head of US Data Strategy - Novartis
• Sundeep Bhan, Chief Executive Officer - Prognos Health
• Kelci Miclaus, PhD, Head of Life Sciences AI - Snowflake

Keynote
Bridging the Data Strategy Gap in Life Sciences

Life Sciences organizations are rethinking how they source, manage, and govern data, but strategies vary widely across the industry. Drawing on a survey of 50 executives across 33 large, mid-size, and emerging life science companies, this keynote unpacks where organizations are investing, where approaches diverge, and what's driving decisions around data governance, privacy, and value creation.

Speaker:
• Florent Moise, Managing Principal, Data Strategy - ZS

Customer Presentation
More Evidence From Every Patient

Hear about how the WeSMA Phase 4 study uses tokenization and record retrieval to build a more complete picture of the patient journey in a rare disease population.

Speaker:
• Kimberly Barnholt, PhD, Executive Director, Head of Data & Clinical Innovation, US Medical - Genentech

Panel
Real-world Data in Clinical Development: Scaling, Globalization, and the Evolving Regulatory Landscape

This panel examines how linked trial and real-world data are reshaping evidence generation in clinical development. Panelists will explore how biopharma organizations are scaling RWD programs across the enterprise, address the challenges of operating in global data environments, and discuss how the field is adapting to a rapidly shifting regulatory landscape.

Moderator: Kathleen Gavin, PhD, Principal, Scientific Solutions - Datavant

Speakers:
• Steve Kundrot, Chief Commercial Officer - TriNetx
• Jen Webster, VP, RWD Strategy and Activation - Pfizer
• Lucinda S. Orsini, DPM, MPH, Vice President, Value and Outcomes Research - Compass Pathways

Make the most of your clinical trial data. Get in touch. →